Proposing a New Frontier in Diabetes Treatment: The Integration of Biotechnology and Artificial Intelligence
J Diabetes Sci Technol
.
2024 Sep;18(5):1245-1246.
doi: 10.1177/19322968241259636.
Epub 2024 Jul 23.
Authors
Lysandro Pinto Borges
1
2
,
Marina Dos Santos Barreto
1
,
Ronaldy Santana Santos
1
,
Eloia Emanuelly Dias Silva
3
,
Deise Maria Rego Rodrigues Silva
1
,
Pedro Henrique Macedo Moura
1
,
Pamela Chaves de Jesus
1
,
Jessiane Bispo de Souza
1
,
Lucas Alves da Mota Santana
4
,
Adriana Gibara Guimarães
1
Affiliations
1
Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.
2
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
3
Department of Biology, Federal University of Sergipe, São Cristóvão, Brazil.
4
Graduate Program in Dentistry, Federal University of Sergipe, São Cristóvão, Brazil.
PMID:
39044476
PMCID:
PMC11418541
(available on
2025-07-23
)
DOI:
10.1177/19322968241259636
No abstract available
Keywords:
artificial intelligence; biotechnology; diabetes; therapeutic.
Publication types
Editorial
Letter
MeSH terms
Artificial Intelligence*
Biotechnology / trends
Diabetes Mellitus* / drug therapy
Diabetes Mellitus* / therapy
Humans